Circulating immune mediators are closely linked in adult-onset type 1 diabetes as well as in non-diabetic subjects

Autoimmunity

Volumn 47, Issue 8, 2014, Pages 530-537

  Fleiner, Hanne Fiskvik ^a   Radtke, Maria ^a,b   Ryan, Liv ^a   Moen, Torolf ^a   Grill, Valdemar ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

BMI; C peptide; Chemokines; Cytokines; Growth factors

Indexed keywords

C PEPTIDE; CHEMOKINE; CYTOKINE; DIAZOXIDE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GLUCAGON; GLUTAMATE DECARBOXYLASE ANTIBODY; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; CCL3 PROTEIN, HUMAN; INSULIN; SIGNAL PEPTIDE;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; AUTOIMMUNITY; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; GENERAL CONDITION DETERIORATION; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MALE; ONSET AGE; PROTEIN BLOOD LEVEL; PROVOCATION TEST; REGULATORY T LYMPHOCYTE; ADOLESCENT; BLOOD; BODY MASS; IMMUNOLOGY; NONPARAMETRIC TEST; PANCREAS ISLET BETA CELL; SECRETION (PROCESS); YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; AUTOIMMUNITY; BODY MASS INDEX; C-PEPTIDE; CHEMOKINE CCL3; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; INSULIN; INSULIN-SECRETING CELLS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84912070822     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2014.938321     Document Type: Article

References (21)

1. Kaas, A., C. Pfleger, L. Hansen, et al. 2010. Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis. Clin. Exp. Immunol. 161: 444-452
2. Pihoker, C., L. K. Gilliam, C. S. Hampe, and A. Lernmark. 2005. Autoantibodies in diabetes. Diabetes 54(Suppl 2): S52-S61
3. Bending, D., P. Zaccone, and A. Cooke. 2012. Inflammation and type one diabetes. Int. Immunol. 24: 339-346
4. Rotondi, M., L. Chiovato, S. Romagnani, et al. 2007. Role of chemokines in endocrine autoimmune diseases. Endocr. Rev. 28: 492-520
5. King, G. L. 2008. The role of inflammatory cytokines in diabetes and its complications. J. Periodontol. 79: 1527-1534
6. Malamitsi-Puchner, A., A. Sarandakou, J. Tziotis, et al. 1998. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus. Pediatr. Res. 44: 873-875
7. Pham, M. N., M. I. Hawa, C. Pfleger, et al. 2011. Pro-And antiinflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: action LADA 4. Diabetologia 54: 1630-1638
8. Nicoletti, F., I. Conget, M. Di Mauro, et al. 2002. Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45: 1107-1110
9. Pfleger, C., H. B. Mortensen, L. Hansen, et al. 2008. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes. Diabetes 57: 929-937
10. Schloot, N. C., P. Hanifi-Moghaddam, N. Aabenhus-Andersen, et al. 2007. Association of immune mediators at diagnosis of Type 1 diabetes with later clinical remission. Diabet. Med. 24: 512-520
11. Bastard, J. P., M. Maachi, C. Lagathu, et al. 2006. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17: 4-12
12. Shoelson, S. E., J. Lee, and A. B. Goldfine. 2006. Inflammation and insulin resistance. J. Clin. Invest. 116: 1793-1801
13. Fain, J. N. 2006. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 74: 443-477
14. Radtke, M. A., I. Nermoen, M. Kollind, et al. 2010. Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of {beta}-cell function and autoimmunity but improves glycemic control. Diabetes Care 33: 589-594
15. Kolb, H., K. Luckemeyer, T. Heise, et al. 2013. The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial). PLoS One 8: e72440
16. Gabbay, M. A., M. N. Sato, A. J. Duarte, and S. A. Dib. 2012. Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients. Clin. Exp. Immunol. 168: 60-67
17. Donath, M. Y., and S. E. Shoelson. 2011. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11: 98-107
18. Nokoff, N. J., M. Rewers, and M. Cree Green. 2012. The interplay of autoimmunity and insulin resistance in type 1 diabetes. Discov. Med. 13: 115-122
19. Wilkin, T. J. 2012. The convergence of type 1 and type 2 diabetes in childhood: the accelerator hypothesis. Pediatr. Diabetes 13: 334-339
20. Schulte, B. M., K. H. Lanke, J. D. Piganelli, et al. 2012. Cytokine and chemokine production by human pancreatic islets upon enterovirus infection. Diabetes 61: 2030-2036
21. Alvarez-Rodriguez, L., M. Lopez-Hoyos, P. Munoz-Cacho, and V. M. Martinez-Taboada. 2012. Aging is associated with circulating cytokine dysregulation. Cell. Immunol. 273: 124-132